Report cover image

Global Quinolones Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 198 Pages
SKU # APRC20359973

Description

Summary

According to APO Research, the global Quinolones market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Quinolones is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Quinolones is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Quinolones market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Quinolones is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Quinolones market include Sanofi, Johnson & Johnson, Novartis, Merck, Bayer, LG Corporation and Allergan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Quinolones, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Quinolones, also provides the sales of main regions and countries. Of the upcoming market potential for Quinolones, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Quinolones sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Quinolones market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Quinolones sales, projected growth trends, production technology, application and end-user industry.

Quinolones Segment by Company

Sanofi
Johnson & Johnson
Novartis
Merck
Bayer
LG Corporation
Allergan
Quinolones Segment by Type

Ciprofloxacin
Gemifloxacin
Norfloxacin
Ofloxacin
Others
Quinolones Segment by Application

Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Quinolones Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Quinolones status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Quinolones market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Quinolones significant trends, drivers, influence factors in global and regions.
6. To analyze Quinolones competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quinolones market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quinolones and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quinolones.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quinolones market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quinolones industry.
Chapter 3: Detailed analysis of Quinolones manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Quinolones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Quinolones in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Quinolones Sales Value (2020-2031)
1.2.2 Global Quinolones Sales Volume (2020-2031)
1.2.3 Global Quinolones Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Quinolones Market Dynamics
2.1 Quinolones Industry Trends
2.2 Quinolones Industry Drivers
2.3 Quinolones Industry Opportunities and Challenges
2.4 Quinolones Industry Restraints
3 Quinolones Market by Company
3.1 Global Quinolones Company Revenue Ranking in 2024
3.2 Global Quinolones Revenue by Company (2020-2025)
3.3 Global Quinolones Sales Volume by Company (2020-2025)
3.4 Global Quinolones Average Price by Company (2020-2025)
3.5 Global Quinolones Company Ranking (2023-2025)
3.6 Global Quinolones Company Manufacturing Base and Headquarters
3.7 Global Quinolones Company Product Type and Application
3.8 Global Quinolones Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Quinolones Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Quinolones Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Quinolones Market by Type
4.1 Quinolones Type Introduction
4.1.1 Ciprofloxacin
4.1.2 Gemifloxacin
4.1.3 Norfloxacin
4.1.4 Ofloxacin
4.1.5 Others
4.2 Global Quinolones Sales Volume by Type
4.2.1 Global Quinolones Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Quinolones Sales Volume by Type (2020-2031)
4.2.3 Global Quinolones Sales Volume Share by Type (2020-2031)
4.3 Global Quinolones Sales Value by Type
4.3.1 Global Quinolones Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Quinolones Sales Value by Type (2020-2031)
4.3.3 Global Quinolones Sales Value Share by Type (2020-2031)
5 Quinolones Market by Application
5.1 Quinolones Application Introduction
5.1.1 Retail Pharmacies
5.1.2 Online Pharmacies
5.1.3 Hospital Pharmacies
5.2 Global Quinolones Sales Volume by Application
5.2.1 Global Quinolones Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Quinolones Sales Volume by Application (2020-2031)
5.2.3 Global Quinolones Sales Volume Share by Application (2020-2031)
5.3 Global Quinolones Sales Value by Application
5.3.1 Global Quinolones Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Quinolones Sales Value by Application (2020-2031)
5.3.3 Global Quinolones Sales Value Share by Application (2020-2031)
6 Quinolones Regional Sales and Value Analysis
6.1 Global Quinolones Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Quinolones Sales by Region (2020-2031)
6.2.1 Global Quinolones Sales by Region: 2020-2025
6.2.2 Global Quinolones Sales by Region (2026-2031)
6.3 Global Quinolones Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Quinolones Sales Value by Region (2020-2031)
6.4.1 Global Quinolones Sales Value by Region: 2020-2025
6.4.2 Global Quinolones Sales Value by Region (2026-2031)
6.5 Global Quinolones Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Quinolones Sales Value (2020-2031)
6.6.2 North America Quinolones Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Quinolones Sales Value (2020-2031)
6.7.2 Europe Quinolones Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Quinolones Sales Value (2020-2031)
6.8.2 Asia-Pacific Quinolones Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Quinolones Sales Value (2020-2031)
6.9.2 South America Quinolones Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Quinolones Sales Value (2020-2031)
6.10.2 Middle East & Africa Quinolones Sales Value Share by Country, 2024 VS 2031
7 Quinolones Country-level Sales and Value Analysis
7.1 Global Quinolones Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Quinolones Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Quinolones Sales by Country (2020-2031)
7.3.1 Global Quinolones Sales by Country (2020-2025)
7.3.2 Global Quinolones Sales by Country (2026-2031)
7.4 Global Quinolones Sales Value by Country (2020-2031)
7.4.1 Global Quinolones Sales Value by Country (2020-2025)
7.4.2 Global Quinolones Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Quinolones Sales Value Growth Rate (2020-2031)
7.5.2 USA Quinolones Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Quinolones Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Quinolones Sales Value Growth Rate (2020-2031)
7.6.2 Canada Quinolones Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Quinolones Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Quinolones Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Quinolones Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Quinolones Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Quinolones Sales Value Growth Rate (2020-2031)
7.8.2 Germany Quinolones Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Quinolones Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Quinolones Sales Value Growth Rate (2020-2031)
7.9.2 France Quinolones Sales Value Share by Type, 2024 VS 2031
7.9.3 France Quinolones Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Quinolones Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Quinolones Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Quinolones Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Quinolones Sales Value Growth Rate (2020-2031)
7.11.2 Italy Quinolones Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Quinolones Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Quinolones Sales Value Growth Rate (2020-2031)
7.12.2 Spain Quinolones Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Quinolones Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Quinolones Sales Value Growth Rate (2020-2031)
7.13.2 Russia Quinolones Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Quinolones Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Quinolones Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Quinolones Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Quinolones Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Quinolones Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Quinolones Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Quinolones Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Quinolones Sales Value Growth Rate (2020-2031)
7.16.2 China Quinolones Sales Value Share by Type, 2024 VS 2031
7.16.3 China Quinolones Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Quinolones Sales Value Growth Rate (2020-2031)
7.17.2 Japan Quinolones Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Quinolones Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Quinolones Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Quinolones Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Quinolones Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Quinolones Sales Value Growth Rate (2020-2031)
7.19.2 India Quinolones Sales Value Share by Type, 2024 VS 2031
7.19.3 India Quinolones Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Quinolones Sales Value Growth Rate (2020-2031)
7.20.2 Australia Quinolones Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Quinolones Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Quinolones Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Quinolones Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Quinolones Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Quinolones Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Quinolones Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Quinolones Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Quinolones Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Quinolones Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Quinolones Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Quinolones Sales Value Growth Rate (2020-2031)
7.24.2 Chile Quinolones Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Quinolones Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Quinolones Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Quinolones Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Quinolones Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Quinolones Sales Value Growth Rate (2020-2031)
7.26.2 Peru Quinolones Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Quinolones Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Quinolones Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Quinolones Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Quinolones Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Quinolones Sales Value Growth Rate (2020-2031)
7.28.2 Israel Quinolones Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Quinolones Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Quinolones Sales Value Growth Rate (2020-2031)
7.29.2 UAE Quinolones Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Quinolones Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Quinolones Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Quinolones Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Quinolones Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Quinolones Sales Value Growth Rate (2020-2031)
7.31.2 Iran Quinolones Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Quinolones Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Quinolones Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Quinolones Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Quinolones Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Sanofi
8.1.1 Sanofi Comapny Information
8.1.2 Sanofi Business Overview
8.1.3 Sanofi Quinolones Sales, Value and Gross Margin (2020-2025)
8.1.4 Sanofi Quinolones Product Portfolio
8.1.5 Sanofi Recent Developments
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Comapny Information
8.2.2 Johnson & Johnson Business Overview
8.2.3 Johnson & Johnson Quinolones Sales, Value and Gross Margin (2020-2025)
8.2.4 Johnson & Johnson Quinolones Product Portfolio
8.2.5 Johnson & Johnson Recent Developments
8.3 Novartis
8.3.1 Novartis Comapny Information
8.3.2 Novartis Business Overview
8.3.3 Novartis Quinolones Sales, Value and Gross Margin (2020-2025)
8.3.4 Novartis Quinolones Product Portfolio
8.3.5 Novartis Recent Developments
8.4 Merck
8.4.1 Merck Comapny Information
8.4.2 Merck Business Overview
8.4.3 Merck Quinolones Sales, Value and Gross Margin (2020-2025)
8.4.4 Merck Quinolones Product Portfolio
8.4.5 Merck Recent Developments
8.5 Bayer
8.5.1 Bayer Comapny Information
8.5.2 Bayer Business Overview
8.5.3 Bayer Quinolones Sales, Value and Gross Margin (2020-2025)
8.5.4 Bayer Quinolones Product Portfolio
8.5.5 Bayer Recent Developments
8.6 LG Corporation
8.6.1 LG Corporation Comapny Information
8.6.2 LG Corporation Business Overview
8.6.3 LG Corporation Quinolones Sales, Value and Gross Margin (2020-2025)
8.6.4 LG Corporation Quinolones Product Portfolio
8.6.5 LG Corporation Recent Developments
8.7 Allergan
8.7.1 Allergan Comapny Information
8.7.2 Allergan Business Overview
8.7.3 Allergan Quinolones Sales, Value and Gross Margin (2020-2025)
8.7.4 Allergan Quinolones Product Portfolio
8.7.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Quinolones Value Chain Analysis
9.1.1 Quinolones Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Quinolones Sales Mode & Process
9.2 Quinolones Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Quinolones Distributors
9.2.3 Quinolones Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.